Stockscreener 앱 받기
0.8101
3.91%
-0.033
시간 외 거래:
.79
-0.0201
-2.48%
전일 마감가:
$0.8431
열려 있는:
$0.8387
하루 거래량:
178.14K
Relative Volume:
0.30
시가총액:
$39.32M
수익:
$1.14M
순이익/손실:
$-72.84M
주가수익비율:
-0.5003
EPS:
-1.6193
순현금흐름:
$-63.64M
1주 성능:
-1.92%
1개월 성능:
+12.64%
6개월 성능:
-45.63%
1년 성능:
-28.31%
1일 변동 폭
$0.7702
$0.8674
1주일 범위
$0.76
$0.90
52주 변동 폭
$0.5301
$2.38
웨어울프 테라 Stock (HOWL) Company Profile
명칭
Werewolf Therapeutics Inc
전화
617-952-0555
주소
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.8101 | 40.92M | 1.14M | -72.84M | -63.64M | -1.6193 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
웨어울프 테라 Stock (HOWL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-04-03 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-24 | 개시 | Wedbush | Outperform |
| 2023-06-06 | 재개 | Jefferies | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-25 | 개시 | Evercore ISI | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | SVB Leerink | Outperform |
모두보기
웨어울프 테라 주식(HOWL)의 최신 뉴스
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Michael J. Urban Net Worth (2026) - GuruFocus
Werewolf Therapeutics (HOWL) eyes 2026 catalysts following FDA guidance and encouraging INDUKINE results - MSN
RSI Check: Is Werewolf Therapeutics Inc stock trending bullishTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Analyst Downgrade: Is now the right time to enter Werewolf Therapeutics IncLayoff News & Real-Time Volume Triggers - baoquankhu1.vn
Werewolf Therapeutics (HOWL) finance VP reports stock and option holdings on Form 3 - Stock Titan
Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN
Werewolf Therapeutics (HOWL) Stock Analysis Report | Financials & Insights - Benzinga Japan
HOWL Stock Price, Quote & Chart | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Published on: 2026-03-05 15:55:35 - baoquankhu1.vn
HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is now the right time to enter Werewolf Therapeutics IncTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Werewolf Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics announces plan to explore strategic alternatives - MSN
Werewolf Therapeutics explores sale and strategic alternatives - Investing.com India
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - Investing News Network
Werewolf Therapeutics Begins Strategic Alternatives Review Process - TipRanks
Werewolf Therapeutics (HOWL) starts review of strategic options with Piper Sandler - Stock Titan
Werewolf Therapeutics explores sale and strategic alternatives By Investing.com - Investing.com South Africa
Levels Update: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
HOWL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Werewolf Therapeutics Inc. stock could rally in 2025Portfolio Gains Summary & Smart Swing Trading Techniques - mfd.ru
IPO Launch: Does Werewolf Therapeutics Inc have strong EBITDA margins2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Asianet Newsable
Werewolf Therapeutics stock falls after announcing 64% workforce reduction - Investing.com
Werewolf Therapeutics Cuts 64% of Workforce - marketscreener.com
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring - TipRanks
Werewolf Therapeutics, Inc. Announces Executive Changes, Effective February 13, 2026 - marketscreener.com
What insider trading reveals about Werewolf Therapeutics Inc. stockMarket Movers & Verified Momentum Stock Ideas - mfd.ru
What is the target price for Werewolf Therapeutics Inc. stock2025 AllTime Highs & Risk Controlled Stock Pick Alerts - mfd.ru
Is Werewolf Therapeutics Inc. impacted by rising ratesWeekly Investment Report & Safe Capital Investment Plans - mfd.ru
Aug Opening: Should I invest in Standard BioTools Inc before earningsWall Street Watch & AI Powered Market Trend Analysis - baoquankhu1.vn
Does Werewolf Therapeutics Inc. have strong EBITDA marginsJuly 2025 Final Week & Daily Stock Trend Watchlist - mfd.ru
Death Cross: Is now the right time to enter Werewolf Therapeutics Inc2025 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Trading Action: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks
Werewolf Therapeutics Received Notice of Noncompliance - TradingView
Bond Watch: What dividend growth rate does ZENA offerInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
Is Werewolf Therapeutics Inc stock trending bullish2025 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Australia
웨어울프 테라 (HOWL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):